| World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access |
| Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc |
| Journal website http://www.wjon.org |
Original Article
Volume 8, Number 3, June 2017, pages 76-80
Uterine Smooth Muscle Tumor of Uncertain Malignant Potential: Clinicopathologic-Sonographic Characteristics, Follow-Up and Recurrence
Tables
| Case 1 | Case 2 | Case 3 | Case 4 | Case 5 | Case 6 | |
|---|---|---|---|---|---|---|
| MM: meno-metrorrhagia. Echogenicity: anechoic, hypoechoic, isoechoic, hyperechoic, mixed (hypo-hyperechoic). Appearence: homogenous, heterogenous. +: present, -: absent. NR: not to be reached. | ||||||
| Age | 48 | 44 | 40 | 43 | 52 | 24 |
| Gravida | 12 | 8 | 2 | 4 | 7 | 0 |
| Parity | 5 | 6 | 2 | 4 | 4 | 0 |
| Menopausal state | Post | Pre | Pre | Pre | Pre | Pre |
| Complaint | MM | MM | MM | MM | MM | MM and pelvic pain |
| Sonographic findings | ||||||
| Number of tumor/myoma | 5 | 1 | 1 | 1 | 1 | 2 |
| Margins of the tumor | Ill-defined | Well-defined | Well-defined | Well-defined | Well-defined | Well-defined |
| Echogenicity | Mixed | Mixed | Hyperechoic | Hyperechoic | Hyperechoic | Hyperechoic |
| Appearance | Heterogenous | Heterogenous | Heterogenous | Heterogenous | Heterogenous | Heterogenous |
| Cystic form | + | + | - | - | - | - |
| Calcification | - | + | + | - | - | + |
| Acoustic shadowing | + | - | - | + | + | + |
| Free fluid | - | - | - | - | - | - |
| Pathology | ||||||
| Procedure | TAH + BSO | TAH + BSO | Myomectomy | TAH + BSO | TAH + BSO | Myomectomy |
| Tumor diameter (cm) | 3.5 | 8 | 7 | 20 | 10 | 8 |
| Localization | Intramural | Submucous | Intramural | Intramural | Intramural | Intramural |
| Number of mitosis (n/10 HPF) | 4 | 17 | 8 | 5 | 8 | 6 |
| Atypia | Mild | Moderate | Moderate | Moderate | Mild | Moderate |
| Necrosis | + | + | - | - | - | - |
| Follow-up (months) | 120 | 119 | NR | 38 | 29 | 11 |
| Recurrence | - | - | NR | - | - | + |
| Age, mean ± SD (min. - max.) | 41.8 ± 9.7 (24 - 52) |
| Gravida, mean ± SD (min. - max.) | 5.5 ± 4.4 (0 - 12) |
| Parity, mean ± SD (min. - max.) | 3.5 ± 2.2 (0 - 6) |
| Menapausal state, n (%) | |
| Postmenapause | 1 (16.7) |
| Premenapause | 5 (83.3) |
| Complaint, n (%) | |
| Meno-metrorrhagia | 6 (100) |
| Sonography | |
| Number of tumor/myoma, mean ± SD (min. - max.) | 1.8 ± 1.6 (1 - 5) |
| Margins of the tumor, n (%) | |
| Ill-defined | 1 (16.7) |
| Well-defined | 5 (83.3) |
| Tumor echogenicity, n (%) | |
| Hyperechoic | 4 (66.7) |
| Mixed | 2 (33.3) |
| Tumor heterogenicity, n (%) | |
| Heterogenous | 6 (100) |
| Cystic appearance, n (%) | |
| + | 2 (33.3) |
| - | 4 (66.7) |
| Calcification n (%) | |
| + | 3 (50.0) |
| - | 3 (50.0) |
| Acoustic shadowing, n (%) | |
| + | 4 (66.7) |
| - | 2 (33.3) |
| Free fluid, n (%) | 0 |
| Pathology | |
| Procedure, n (%) | |
| Myomectomy | 2 (33.3) |
| TAH + BSO | 4 (66.7) |
| Tumor diameter (cm), mean ± SD (min. - max.) | 9.4 ± 5.6 (3.5 - 20) |
| Localization, n (%) | |
| Intramural | 5 (83.3) |
| Submucous | 1 (16.7) |
| Mitosis count (n/10 HPF), mean ± SD (min. - max.) | 8.0 ± 4.7 (4 - 17) |
| Atypia, n (%) | |
| Mild | 2 (33.3) |
| Moderate | 4 (66.7) |
| Necrosis, n (%) | |
| + | 2 (33.3) |
| - | 4 (66.7) |
| Final situation n (%) | |
| Recurrence | 1 (20) |
| Disease-free | 4 (80) |
| NR | 1 |
| Follow-up (months), mean ± SD (min. - max.) | 63.4 ± 52.1 (11 - 120) |